AAIC 2025 Abstract
Repurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform Trial
Abstract
Background: Despite recent developments in amyloid‐clearing therapies for Alzheimer's Disease (AD), there remains a need for more effective, safe treatments.
